Developing a Clinical Outcome Assessment for Opioid Craving
NCT05109429 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81
Last updated 2025-10-23
Summary
The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid craving assessment to improve treatments for individuals with opioid use disorder. To collect this information, the investigators are recruiting individuals in treatment for opioid use disorder who will complete cue-induced opioid craving tasks where these individuals will: (1) look at pictures of neutral objects and touch neutral objects (e.g., water bottles or flashlights), (2) look at opioid-related images, and (3) look and touch opioid-related objects. Participants will then complete a one-on-one interview about the thoughts, feelings and physical sensations the participants experienced during the cue-induced craving session. Participants will also complete questionnaires and existing opioid craving assessments. Finally, participants will provide formal feedback about existing opioid craving assessments with cognitive interviews.
Conditions
- Opioid Craving
- Opioid Use Disorder
- Measure Development
Interventions
- BEHAVIORAL
-
Neutral Cue-induced Craving
For the neutral cue condition, the participant will be seated in front of a 16-inch monitor and instructed to sit upright to view 20 pictures of water bottles via E-Prime software (Psychology Software Tools Inc., PA), presented for five seconds each in randomized order. The images will include pictures of a water bottle alone, water being poured from a bottle to a glass, and an individual drinking from a bottle of water. Next, participants will watch as research staff open a bottle of water, pour it into a glass, and place it on a table in front of the participant. Participants will also be asked to look at a water bottle, hold it, sniff it, and take a drink of water.
- BEHAVIORAL
-
Visual Opioid Cue-induced Craving
For the visual opioid cue-induced craving condition, the participant will again be seated in front of a 16-inch monitor and instructed to sit upright to view 20 pictures of opioid-related imagery, presented for five seconds each in a randomized order. The opioid-related imagery will be customized for heroin or prescription opioids based upon the participant's primary opioid of choice. The images will include pills and white powder, stages of drug taking preparation (e.g., holding spoon over flame, pills being crushed).
- BEHAVIORAL
-
Visual and Tactile Opioid Cue-induced Craving
For the visual and tactile opioid cue condition, procedures will differ depending on the participants' most preferred route of administration. . Intranasal users will be instructed to watch as research staff opens a wallet, removes a $1 bill, removes a packet of powder mimicking heroin/crushed pills, open the packet, and roll the dollar bill. The participant will then be given the packet and the dollar bill to hold for approximately 30 seconds. Intravenous users will be instructed to watch the research nurse open the packet of fake heroin, pour its contents into a spoon, added a few drops of water to the spoon, hold an open flame from a lighter under the spoon, add cotton to the spoon, and draw the fluid into a syringe.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Cecilia L Bergeria, PhD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-03
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
Screening Protocol for the Evaluation of Potential Research Subjects
NCT01036971 ·Status: COMPLETED
-
Frontoparietal Synchronization to Modulate Drug Craving in Opioid Use Disorder
NCT03907644 ·Status: COMPLETED ·Phase: NA
-
Automatic Versus Evaluative Components of Cue Reactivity
NCT01036126 ·Status: COMPLETED
-
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
NCT05610072 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET Assays of Striatal Dopamine Marker in Cocaine Craving
NCT01036516 ·Status: COMPLETED
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction
NCT07344233 ·Status: COMPLETED ·Phase: NA
-
Pain Catastrophizing and Prescription Opioid Craving
NCT04097743 ·Status: TERMINATED ·Phase: NA
-
Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
NCT00000316 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
NCT03950492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Brain Dopaminergic Signaling in Opioid Use Disorders
NCT03190954 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
NCT00000315 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility and Validation of a Standard Phenotyping Assessment Battery
NCT03495869 ·Status: COMPLETED
-
Pharmacotherapy & CM for Opioid and Cocaine Dependence
NCT00838981 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
[11C]NOP-1A and Cocaine Use Disorders
NCT03348384 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1
NCT00218660 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment for Caffeine Dependence
NCT01951872 ·Status: COMPLETED ·Phase: NA
-
AAT + tDCS to Reduce Cue-induced Craving and Smoking Behavior
NCT05426460 ·Status: COMPLETED ·Phase: NA
-
Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates
NCT00865332 ·Status: WITHDRAWN
-
Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans
NCT01605539 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
NCT00292110 ·Status: COMPLETED ·Phase: PHASE1
-
Modification of Cue Reactivity by Neurofeedback in Human Addiction
NCT04366505 ·Status: UNKNOWN ·Phase: NA
-
Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants
NCT02935101 ·Status: TERMINATED ·Phase: PHASE2
-
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
NCT00628927 ·Status: COMPLETED